Cargando…
Idalopirdine, a selective 5-HT(6) receptor antagonist, reduces food intake and body weight in a model of excessive eating
Obesity, from early childhood onwards, is a common societal problem. The overconsumption of sweet, salty and high-fat products are the main factors that cause excessive weight gain. It is therefore necessary to search for new drugs that affect satiety centers and reduce the sense of hunger and calor...
Autores principales: | Kotańska, Magdalena, Lustyk, Klaudia, Bucki, Adam, Marcinkowska, Monika, Śniecikowska, Joanna, Kołaczkowski, Marcin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956042/ https://www.ncbi.nlm.nih.gov/pubmed/29297106 http://dx.doi.org/10.1007/s11011-017-0175-1 |
Ejemplares similares
-
Idalopirdine – a small molecule antagonist of 5-HT(6) with therapeutic potential against obesity
por: Dudek, Magdalena, et al.
Publicado: (2015) -
Metabolic and Cardiovascular Benefits and Risks of EMD386088—A 5-HT(6) Receptor Partial Agonist and Dopamine Transporter Inhibitor
por: Kotańska, Magdalena, et al.
Publicado: (2017) -
Synthesis and biological evaluation of N-arylpiperazine derivatives of 4,4-dimethylisoquinoline-1,3(2H,4H)-dione as potential antiplatelet agents
por: Marcinkowska, Monika, et al.
Publicado: (2018) -
Dual Molecules
Targeting 5-HT(6) and
GABA-A Receptors as a New Approach to Combat Depression Associated
with Neuroinflammation
por: Marcinkowska, Monika, et al.
Publicado: (2023) -
Management of Dementia-Related Psychosis, Agitation and Aggression: A Review of the Pharmacology and Clinical Effects of Potential Drug Candidates
por: Marcinkowska, Monika, et al.
Publicado: (2020)